Innovation Observatory > Reports > Drugs > VF-001 (VitroGro ECM) for venous leg ulcer

< Back

VF-001 (VitroGro ECM) for venous leg ulcer


Cancer and Palliative Care

June 2017

VF-001 is a new drug that enables and accelerates chronic wound repair by providing cell attachment sites and stimulating cell activity. Consequently, skin cells are able to attach, migrate and increase rapidly to restore the wound healing process.VF-001 is applied to the wound weekly, and fits with standard care for chronic wounds. The wound closes, breaking the cycle of inflammation, and leaving healthy, functional tissue.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Connect to the Innovation Observatory



Related Information

Load More Related Posts
Get Alerts